Get started
Armata Pharmaceuticals, Inc.Armata Pharmaceuticals, Inc.Armata Pharmaceuticals, Inc.

Armata Pharmaceuticals, Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

ARMP chart


Full chart

ARMP upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪70.56 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−1.15 USD
Net income (FY)
‪−69.05 M‬ USD
Revenue (FY)
‪4.53 M‬ USD
Shares float
‪10.76 M‬
Beta (1Y)
1.61

Employees


Employees (FY)
66
Change (1Y)
−9 −12.00%
Revenue / Employee (1Y)
‪68.62 K‬ USD
Net income / Employee (1Y)
‪−1.05 M‬ USD

About Armata Pharmaceuticals, Inc.


Sector
Health Technology
Industry
Biotechnology
CEO
Deborah L. Birx
Website
armatapharma.com
Headquarters
Los Angeles
Founded
1989
FIGI
BBG000BD7CF8
Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, which focuses on the development of bacteriophage therapeutics for the treatment of drug-resistant bacterial infections. The company was founded in 1989 and is headquartered in Los Angeles, CA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

ARMP news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of ARMP is 1.95 USD — it has decreased by −1.52% in the past 24 hours. Watch Armata Pharmaceuticals, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on AMEX exchange Armata Pharmaceuticals, Inc. stocks are traded under the ticker ARMP.
ARMP stock has fallen by −7.54% compared to the previous week, the month change is a −2.01% fall, over the last year Armata Pharmaceuticals, Inc. has showed a −18.75% decrease.
We've gathered analysts' opinions on Armata Pharmaceuticals, Inc. future price: according to them, ARMP price has a max estimate of 7.00 USD and a min estimate of 7.00 USD. Watch ARMP chart and read a more detailed Armata Pharmaceuticals, Inc. stock forecast: see what analysts think of Armata Pharmaceuticals, Inc. and suggest that you do with its stocks.
ARMP reached its all-time high on Feb 18, 2000 with the price of 1,960,000.00 USD, and its all-time low was 0.83 USD and was reached on Dec 28, 2022. View more price dynamics on ARMP chart.
See other stocks reaching their highest and lowest prices.
ARMP stock is 5.26% volatile and has beta coefficient of 1.61. Track Armata Pharmaceuticals, Inc. stock price on the chart and check out the list of the most volatile stocks — is Armata Pharmaceuticals, Inc. there?
Today Armata Pharmaceuticals, Inc. has the market capitalization of ‪70.56 M‬, it has decreased by −9.05% over the last week.
Yes, you can track Armata Pharmaceuticals, Inc. financials in yearly and quarterly reports right on TradingView.
Armata Pharmaceuticals, Inc. is going to release the next earnings report on Mar 13, 2025. Keep track of upcoming events with our Earnings Calendar.
ARMP earnings for the last quarter are −0.15 USD per share, whereas the estimation was −0.28 USD resulting in a 46.43% surprise. The estimated earnings for the next quarter are −0.35 USD per share. See more details about Armata Pharmaceuticals, Inc. earnings.
Armata Pharmaceuticals, Inc. revenue for the last quarter amounts to ‪2.97 M‬ USD, despite the estimated figure of ‪900.00 K‬ USD. In the next quarter, revenue is expected to reach ‪1.56 M‬ USD.
ARMP net income for the last quarter is ‪−5.48 M‬ USD, while the quarter before that showed ‪8.99 M‬ USD of net income which accounts for −160.99% change. Track more Armata Pharmaceuticals, Inc. financial stats to get the full picture.
No, ARMP doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 22, 2024, the company has 66.00 employees. See our rating of the largest employees — is Armata Pharmaceuticals, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Armata Pharmaceuticals, Inc. EBITDA is ‪−40.25 M‬ USD, and current EBITDA margin is −881.39%. See more stats in Armata Pharmaceuticals, Inc. financial statements.
Like other stocks, ARMP shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Armata Pharmaceuticals, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Armata Pharmaceuticals, Inc. technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Armata Pharmaceuticals, Inc. stock shows the strong sell signal. See more of Armata Pharmaceuticals, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.